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Abstract
Corruption in the health sector has been a “dirty secret” in the health policy and international development 
community, but recent global activities point to a day when it will no longer be neglected as a key determinant 
of health. To further explore next steps forward, this commentary applies the Kingdon’s multiple-streams 
framework (MSF) to assess what opportunities are available to mobilize the global agenda to combat health 
corruption. Based on this analysis, it appears that Kingdon’s problem, policy, and political streams are coalescing 
to create a policy window opportunity that can be leveraged based on recent developments in the global health 
and international development community around corruption. This includes the recent formation of the 
Global Network on Anti-Corruption, Transparency and Accountability (GNACTA) led by the World Health 
Organization (WHO), the Global Fund, and the United Nations Development Programme in 2019. It also 
includes bridging shared goals of addressing corruption in order to make progress towards health-specific goals 
in the United Nations (UN) Sustainable Development Goals (SDGs) and for achieving universal health coverage. 
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Corruption in the health system has indeed been a “dirty secret” in health policy and international development circles as mentioned in the article “We Need to Talk 
About Corruption in Health Systems” by Hutchinson and 
colleagues.1 However, health corruption, while still “dirty,” 
is becoming less “secret,” with a growing number of studies 
explicitly linking the estimated $300 billion US dollars lost 
yearly to health sector corruption to poor health outcomes, 
faltering health systems and even patient death.2-5 In this 
sense, the various manifestations of health corruption are 
no longer unknown – we now know and recognize that it is 
a major barrier to shared goals of sustainable development, 
health equity, and achieving universal health coverage.6,7 
The challenge now is moving the fight against corruption 
to the next phase, which means putting in the hard work 
of cultivating the necessary partnerships, generating data, 
developing tools, and mobilizing political will to detect, 
characterize, prevent, and enforce against corruption as a key 
priority for the future of global health. 
Reflecting some of these challenges, Hutchinson et al 
describe their five reasons explaining why corruption has yet 
to break through in the international health policy discourse. 
Many of these challenges are familiar to anti-corruption 
experts including: lack of a concrete definition for corruption 
(particularly given the various types and forms of corruption 
and its cultural context), the need to address the real-world 
practicalities of why corruption exists in fragile health 
systems (eg, the use of informal payments to access healthcare 
services), difficulties in conducting empirical research on 
health corruption practices (particularly in the context of lack 
of transparency, accountability and difficulty in collecting 
corruption-related data), and the challenging ethical barriers 
of researching, implementing, and evaluating anti-corruption 
activities, particularly when the subjects of said corrupt 
activities (including individual actors involved in sporadic or 
petty corruption up to policy-makers/politicians involved in 
institutional and political corruption) are complicit, benefit, 
or are directly involved in the corruption itself.1,8,9 
Authors also ask the fundamental question of whether 
it is legitimate to study corruption, while also highlighting 
findings from a 2016 Cochrane review by Gaitonde et al that 
found limited evidence for the effectiveness of anti-corruption 
strategies.10 While these observations are valid concerns, 
it does not take away from the fact that the study of health 
corruption is not just legitimate but is now being recognized 
by a number of different international stakeholders as crucial 
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to the current and future success of global health programs 
and initiatives as outlined below.5 
Authors conclude that there is a need to convene key 
stakeholders to debate, reach consensus, and develop an 
international agenda to empower people to talk about 
corruption in health systems. Here, authors should be 
encouraged that such activities are already underway and 
have new and exciting support from the international 
community. Specifically, this includes the recent formation 
of the Global Network on Anti-Corruption, Transparency 
and Accountability (GNACTA) led by the World Health 
Organization (WHO), the Global Fund, and the United Nations 
Development Programme in 2019. As key organizations 
representing constituencies in the international public 
health, multilateral global health funding, and international 
development spheres, GNACTA is positioned to act as a key 
health anti-corruption fora now and into the future provided 
it receives appropriate support and a strong mandate to take 
action. Hutchinson et al also suggest the need to prioritize 
actions based on risk to vulnerable groups and impact on 
health systems. This is a logical conclusion, but one that is 
already being carried out in the field through risk-based fraud, 
auditing, and law enforcement practices.5,7 Hence, efforts are 
well underway, but the journey to adequately control health 
sector corruption will be continuous as corruption simply 
cannot be eradicated like an infectious disease, instead it is 
chronic to healthcare systems. 
In response, this commentary focuses not on the limitations 
of tackling health sector corruption, but the opportunities 
to leverage existing international momentum by adopting 
John Kingdon’s multiple-streams framework (MSF) to 
identify priorities needed to address this seminal global 
health challenge.11 The piece focuses on applying MSF to the 
examination of existing policy, programmatic, and governance 
frameworks, such as GNACTA (https://hsgovcollab.org/
en/event/consultation-proposed-global-network-anti-
corruption-transparency-and-accountability-health), the 
United Nations (UN) Sustainable Development Goals (SDGs) 
(https://sustainabledevelopment.un.org/sdgs), and the UN 
Convention against Corruption (UNCAC) (https://www.
unodc.org/unodc/en/treaties/CAC/), and how they can form 
a unique convergence event for a “policy window” to mobilize 
anti-corruption global health governance. 
Kindgon’s Policy Window for Health Anti-corruption?
It has been over 30 years since John Kingdon first published 
the MSF in his book “Agendas, Alternatives and Public 
Policies,” which originally focused on public policy agenda 
setting in the US domestic policy context.11 However, 
Kingdon’s MSF continues to hold relevance today, including 
in the area of comparative policy analysis and health systems 
research.12 Simply put, MSF examines agenda setting processes 
focusing on three “streams” including the “problem stream,” 
“policy stream,” and the “political stream” that primarily act 
independently. However, when these streams converge, they 
create an opportunity for a “policy window” that can help 
facilitate policy change.12 Below we describe each of these 
streams and how they can create a global policy window 
specific to mobilizing international anti-corruption efforts in 
the health sector.
The first MSF stream is the problem stream, which 
begins with recognition of a public problem that requires 
government or state action for resolution. The problem 
stream requires elevating attention to public matters so they 
can be recognized and acted upon by decision-makers (eg, 
policy-makers and political leaders). Garnering attention or 
political pressure to a problem often requires dramatic events 
that raise awareness to the issue simultaneously among the 
public and policy-makers audiences. When politicians or 
government official decision-makers themselves are directly 
implicated in corruption, this is particularly challenging, 
often requiring public outrage, civil society mobilization, anti-
corruption advocacy campaigns (eg, letter writing and online 
campaigns, petitions, earned and traditional media, etc), and 
even litigation in the hopes of mobilizing anti-corruption 
coalitions or creating pressure for government/regime change 
or anti-corruption policy-making. 
From a macro historical level, taking corruption out of the 
shadows and elevating it to the problem stream has occurred 
through a progression of important voices that have helped 
de-stigmatize the word “corruption.” This includes the 
seminal 1996 speech by former World Bank President James 
Wolfensohn’s, calling for global action against the “cancer 
of corruption,” to more recent statements by former World 
Bank President Jim Yong Kim, who denounced corruption as 
“public enemy number one,” and former US Secretary of State 
John Kerry, who characterized corruption as a “pandemic.”7
Further, high-profile events such as allegations of corruption 
and misuse of funds in the Global Fund’s portfolio reported 
by the Associated Press in 2011 have raised alarms across the 
global health and international development aid communities, 
as well as rebuke from donors.7,13 This event, though viewed as 
damaging to overall global health prospects, can also be seen 
as a critical juncture in bringing needed recognition that the 
presence of corruption, no matter the size (as reports of the 
$34 million in missing funds for this incident were less than 
1% of the Global Fund’s total grant portfolio) has the power 
to undermine the integrity of multibillion dollar global health 
programs, hence elevating the issue to the problem stream.7 
Public awareness and fear of health corruption has also 
appeared in domestic survey data where the Kaiser Family 
Foundation found that corruption is viewed as the biggest 
barrier to improving health in developing countries among 
US respondents.5 This is particularly important as the United 
States remains the top source for development assistance for 
health.14 
Second, the MSF policy stream involves the conceptualization 
and proposal of solutions to address identified problems. 
More simply, if a problem is identified but has no policy 
solution, then it cannot be acted upon or included in the 
decision-making agenda.11 Hence, decision-makers will 
prioritize problems that already have needed solutions in 
place, though those decision-makers involved in corruption 
(whether they be democratically elected representatives, 
technocrats, or non-democratic regimes) themselves may 
either block, amend, or refocus solutions to externalize the 
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problem based on their own preferences, particularly in the 
case of systemic corruption or state capture. Hence, there 
is a need for a broad base of proposed solutions that can be 
generated by experts (including academia, civil society, and 
other stakeholders) and can then be independently assessed 
for action or inaction, narrowed to those that represent 
feasible policy change options, and then championed by a 
broad coalition of anti-corruption constituents to pressure 
political action and accountability. Here, though evidence to 
support the effectiveness of anti-corruption measures remains 
relatively weak, the necessary collection of experts that can 
create multisector solutions to address health corruption is 
rapidly taking shape. GNACTA represents such a convening 
place to generate diverse anti-corruption solution options 
that can be designed in conjunction with existing national 
law and internationally binding legal instruments coupled 
with multistakeholder advocacy and technical assistance to 
countries. 
Existing domestic and international policy instruments that 
can be leveraged as solutions include UNCAC, a universal 
anti-corruption instrument that focuses on prevention, 
criminalization, international cooperation, asset recovery, 
and technical assistance and information exchange, which 
can be specifically tailored to corruption in the health sector.9 
It also includes domestic anti-corruption laws, such as the US 
Foreign Corrupt Practices Act and the UK Bribery Act, whose 
influence could be extended by adoption of similar laws and 
regulations in other countries. Critically, health corruption 
is a trans-sectoral issue, particularly in the context of how 
corruption negatively impacts the social determinants of 
health and health equity. Hence, anti-corruption approaches 
cannot simply be limited to the health sector and instead 
should be focused on trans-sectoral interventions in other 
industrial, economic, and social spaces. Legal, treaty, and 
governance instruments such as UNCAC, the US Foreign 
Corrupt Practices Act, the UK Bribery Act, and the SDGs 
represent optimal convening places to tackle corruption from 
this trans-sectoral approach. 
The third “politics stream” is made up of factors that 
are political in nature (eg, changes in governments/
administrations, upswing in public opinion, and increased 
advocacy/lobbying) that can ostensibly generate the political 
will needed to take action against a problem. Here again, 
GNACTA’s formation represents a critical opportunity for 
mobilizing both partnership but also multistakeholder 
advocacy around combating health corruption. Collectively, 
GNACTA enjoys the participation of members from 
international organizations, multilateral development 
agencies, academia, national government officials, and civil 
society, all of whom can collectively advocate to their national 
governments and the UN system under a unified voice and 
multistakeholder platform. Bolstering GNACTA is also 
the UN SDGs, which via Goals 3 and 16 provide evidence 
of global consensus (including specific SDG targets and 
indicators) that improving health and combating corruption 
are key pillars for 21st century development.6 
Hence, the converge of the MSF “problem,” “policy,” and 
“political” streams around health corruption appear to be 
taking place. Specifically, the “problem” of health corruption 
is now evident in the increased number of publications around 
the subject (including a special collection of health corruption 
articles currently being developed with partnership from the 
WHO) and recognition of the problem through civil society 
advocacy and international meetings such as the 2016 Anti-
Corruption Summit held by former UK Prime Minister 
David Cameroon. The “policy stream” is also maturing with 
domestic and international anti-corruption instruments to 
enforce against corruption and global governance approaches 
included in the SDGs to measure health and corruption-
related indicators as a measure of progress towards sustainable 
development. Finally, the “political” stream is also emerging, 
with recognition of the unique dangers of health corruption 
among various international organizations personified by 
GNACTA, but also included at the recent G20 Osaka Summit 
where the topics of global health and anti-corruption were 
both included in the G20 Osaka Leaders’ Declaration.15 
Lastly, the rise of autocratic regimes in certain countries 
has raised the profile of corruption among the broader public. 
This includes high-income countries such as the United States, 
where public perception and concerns about corruption in 
government and the executive branch are becoming more 
pronounced.16,17 Hence, signs are pointing to greater public 
awareness and fear of the influence of corruption, potentially 
unlocking the final stream of public awareness that can force 
the “opening” of a health corruption Kingdon policy window. 
Conclusion
As the streams of problem, policy, and politics converge 
around corruption, a policy window appears to be 
materializing that can take us to the next phase of fighting 
corruption in health. Further, beyond policy and governance-
focused approaches, specific anti-corruption solutions, such 
as targeted risk assessment using a heat map to prioritize 
anti-corruption interventions for issues with the highest 
likelihood and negative impact, evaluation frameworks that 
trace impact on financial, performance, and health indicators, 
and good governance tools (such as the WHO Good 
Governance for Medicines tool), are already in place and 
ready to be utilized.18 Another important solution area are new 
technology applications that could represent next generation 
solutions, powered by innovations in data mining, machine 
learning, and emerging technologies such as blockchain.7,19 
In fact, during the inaugural GNACTA meeting in Geneva, 
Switzerland, an “Experience Exchange Marketplace” was held 
where select participants shared their research and results 
from anti-corruption solutions and case studies providing 
examples of health anti-corruption in practice. Importantly, 
establishing a research agenda to empirically test these 
solutions is necessary to support evidence-based policy-
making and implementation in the field, though that should 
not delay the maturing of a robust “policy” and “solution” 
stream for health corruption. 
The success of GNACTA will be critical to opening 
Kingdon’s policy window and walking through it. However, 
I am already encouraged by progression made since my first 
publication on health corruption in 2012, when reviewers 
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from certain journals commented that corruption was 
important, but we in the global health community should not 
talk about it as it could negatively impact all the great work 
being done in global health. Now, that attitude has shifted 
with anti-corruption research being encouraged, meetings 
and open debate supported by international organizations, 
and the word “corruption” in the health sector no longer 
being whispered.
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